Skip to main content

Orphenadrine Citrate

NDC 50090-0169 · A-S Medication Solutions

Generic nameORPHENADRINE CITRATE
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)ORPHENADRINE CITRATE
Strength100 mg/1
Pharmacologic classCentrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
Marketing categoryANDA

Packages

50090-0169-0 — 20 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-0169-0)

50090-0169-1 — 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-0169-1)

50090-0169-5 — 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-0169-5)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0185-0022 — Orphenadrine Citrate, 0591-3222 — Orphenadrine Citrate, 0641-6182 — Orphenadrine citrate, 25021-651 — orphenadrine citrate, 43063-407 — ORPHENADRINE CITRATE, 43386-480 — ORPHENADRINE CITRATE, 49999-046 — Orphenadrine Citrate, 50991-999 — Orphenadrine Citrate, Aspirin and Caffeine, 60760-810 — Orphenadrine Citrate, 61825-302 — Orphenadrine Citrate, Aspirin and Caffeine, 61825-305 — Orphenadrine Citrate, Aspirin and Caffeine, 63187-122 — Orphenadrine Citrate, 63187-632 — Orphenadrine Citrate, 63629-1564 — ORPHENADRINE CITRATE, 66267-158 — Orphenadrine Citrate, 67296-1077 — Orphenadrine Citrate, 68788-9138 — Orphenadrine Citrate, 70518-4506 — ORPHENADRINE CITRATE, 71993-304 — Orphenadrine Citrate, Aspirin and Caffeine, 71993-307 — Orphenadrine Citrate, Aspirin and Caffeine, +4 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels